{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:10:16Z","timestamp":1682658616408},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.lfs.2003.12.003","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T17:09:07Z","timestamp":1079802547000},"page":"63-75","source":"Crossref","is-referenced-by-count":6,"title":["Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activation"],"prefix":"10.1016","volume":"75","author":[{"given":"Antonella","family":"D'Ambrosio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Noviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Negri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Schmidhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Quintieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2003.12.003_BIB1","first-page":"738","article-title":"Immunosuppression by delta opioid receptor antagonist","volume":"25","author":"Arakawa","year":"1993","journal-title":"Transplantion Proceedings"},{"key":"10.1016\/j.lfs.2003.12.003_BIB2","first-page":"696","article-title":"Immunosuppressive effect of delta-opioid receptor antagonist on xenogenic mixed lymphocyte reaction","volume":"24","author":"Arakawa","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1016\/j.lfs.2003.12.003_BIB3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid-dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2003.12.003_BIB4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0162-3109(92)90035-B","article-title":"Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility","volume":"23","author":"Bayer","year":"1992","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB5","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1522-2675(20010711)84:7<2015::AID-HLCA2015>3.0.CO;2-1","article-title":"Novel delta-opioid -receptor-selective ligands in the 14-alkoxy-substituted indolo- and benzofuromorphinan series","volume":"84","author":"Biyashev","year":"2001","journal-title":"Helvetica Chimica Acta"},{"key":"10.1016\/j.lfs.2003.12.003_BIB6","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1079\/BJN2002682","article-title":"The immune system: a target for functional foods?","volume":"88","author":"Calder","year":"2002","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10.1016\/j.lfs.2003.12.003_BIB7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000097148","article-title":"A reappraisal of the role of the various opioid receptor subtypes in cell mediated immunity","volume":"1","author":"Caroleo","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.lfs.2003.12.003_BIB8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(90)90040-T","article-title":"Corticotropin releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway","volume":"28","author":"Carr","year":"1990","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0008-8749(88)90208-0","article-title":"Evidence for \u03b4-class opioid receptor on cells of the immune system","volume":"116","author":"Carr","year":"1988","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.1994.2071","article-title":"Delta opioid receptor gene expression in lymphocytes","volume":"202","author":"Chuang","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.lfs.2003.12.003_BIB11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1995.2709","article-title":"Mu opioid receptor gene expression in immune cells","volume":"216","author":"Chuang","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.lfs.2003.12.003_BIB12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-5793(95)00766-3","article-title":"Identification of \u03ba- and \u03b4-opioid receptor transcripts in immune cells","volume":"369","author":"Gaveriaux","year":"1995","journal-title":"FEBS Letters"},{"key":"10.1016\/j.lfs.2003.12.003_BIB14","first-page":"1193","article-title":"Immunosuppression by \u03b4-opioid antagonist naltrindole: \u03b4 and triple \u03c5\/\u03b4\/\u03ba-opioid receptor knockout mice reveal a nonopioid activity","volume":"298","author":"Gav\u00e9riaux-Ruff","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.lfs.2003.12.003_BIB15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-3940(95)11983-4","article-title":"Suppression of immune function by non peptidic delta opioid receptor antagonists","volume":"198","author":"House","year":"1995","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.lfs.2003.12.003_BIB16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0196-9781(95)02051-9","article-title":"A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides","volume":"17","author":"House","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2003.12.003_BIB17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0165-5728(01)00313-7","article-title":"Identification of delta- and mu-type opiod receptors on human and murine dendritic cells","volume":"117","author":"Makarenkova","year":"2001","journal-title":"Journal of Neuroimmunol"},{"key":"10.1016\/j.lfs.2003.12.003_BIB18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-2478(93)90144-Q","article-title":"Immunomodulation of human T cell responses with receptor selective enkephalins","volume":"35","author":"Mazumder","year":"1993","journal-title":"Immunology Letters"},{"key":"10.1016\/j.lfs.2003.12.003_BIB19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.lfs.2003.12.003_BIB20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00007691-199512000-00012","article-title":"Mechanisms of action and overwiew of OKT3","volume":"17","author":"Norman","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.lfs.2003.12.003_BIB21","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01123-0","article-title":"Immunomodulatory responses to delta opioid receptor ligands in human lymphocytes","volume":"332","author":"Noviello","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-3083.1986.tb03075.x","article-title":"Inhibition of in vitro alloreactivity by cyclosporin A: evidence for an inter-individual variation in sensitivity","volume":"23","author":"Sander","year":"1986","journal-title":"Scandinavian Journal of Immunology"},{"issue":"24","key":"10.1016\/j.lfs.2003.12.003_BIB23","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1021\/jm020940p","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinans","volume":"45","author":"Sch\u00fctz","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.lfs.2003.12.003_BIB24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0065-2776(08)60380-6","article-title":"Lectin receptors as lymphocyte suface markers","volume":"34","author":"Sharon","year":"1983","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0165-5728(96)00120-8","article-title":"Expression of opioid receptor by immune cells","volume":"69","author":"Sharp","year":"1996","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(97)00220-8","article-title":"Evidence for opioid receptors on cells involved in host defence and the immune system","volume":"83","author":"Sharp","year":"1998","journal-title":"Jounal of Neuroimmunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.iy.06.040188.001251","article-title":"Opioid peptides and opioid receptors in cells of the immune system","volume":"6","author":"Sibinga","year":"1988","journal-title":"Annual Review in Immunology"},{"issue":"8","key":"10.1016\/j.lfs.2003.12.003_BIB28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0167-5699(97)01101-8","article-title":"B-cell superantigens","volume":"18","author":"Silverman","year":"1997","journal-title":"Immunology Today"},{"key":"10.1016\/j.lfs.2003.12.003_BIB29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/smim.1997.0104","article-title":"B-cell superantigens: possible roles in immunodeficiency and autoimmunity","volume":"10","author":"Silverman","year":"1998","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB30","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0024-3205(01)01271-1","article-title":"Binding, pharmacological and immunological profiles of the \u03b4-selective opioid receptor antagonist HS 378","volume":"69","author":"Spetea","year":"2001","journal-title":"Life Sciences"},{"issue":"4760","key":"10.1016\/j.lfs.2003.12.003_BIB31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.3523754","article-title":"Interleukin-2 induction of T-cell G1 progression and c-myb expression","volume":"233","author":"Stern","year":"1986","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lfs.2003.12.003_BIB32","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4049\/jimmunol.124.6.2708","article-title":"OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties","volume":"124","author":"Van Wauwe","year":"1980","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.lfs.2003.12.003_BIB33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-5728(95)00144-1","article-title":"Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes","volume":"64","author":"Wick","year":"1996","journal-title":"Journal of Neuroimmunology"},{"issue":"3","key":"10.1016\/j.lfs.2003.12.003_BIB34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-1759(81)90174-5","article-title":"Propidium iodide as a nuclear marker in immunofluorescence: II. Use with cellular identification and viability studies","volume":"43","author":"Yeh","year":"1981","journal-title":"J Immunological Methods"},{"issue":"8","key":"10.1016\/j.lfs.2003.12.003_BIB35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0167-5699(95)80009-3","article-title":"B-cell superantigens: implications for selection of the human antibody repertoire","volume":"16","author":"Zouali","year":"1995","journal-title":"Immunology Today"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320504002085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320504002085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:46:02Z","timestamp":1682657162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320504002085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0024320504002085"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2003.12.003","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}